FY23 Full-Year Results Presentation
Regis Healthcare Limited | FY23 Full-Year Results Presentation
Net Debt and Cash Flow
$ millions
Facility A
Purpose
Limit
Working capital
150.0
March 2026
Facility B
Working capital
175.0
March 2027
Residential village
Facility C
70.0
March 2027
developments
Facility D
LC/bank guarantees
10.0
March 2027
Total Syndicated Facility
405.0
Net Debt
Maturity
Net Debt Movements ($m)
102.9
(71.5)
► $96.9 million reduction in net debt driven by operating cash flow and investing activities
•
Net cash inflow from operating activities of $105.2 million, including net RAD cash
inflow of $43.6 million
• $60 million proceeds from sale of non-income producing assets including the
Hollywood retirement village and vacant land in WA
$53.5 million investment in capital expenditure including the purchase of development
land at Carlingford, NSW and strategic technology investment
►Net debt reduced 98.5% over last 5 years from $403.8 million at 30 June 2018 to
$6.0 million at 30 June 2023
► Facilities B, C and D refinanced through to March 2027
• Regis elected to reduce the total facility from $515 million to $405 million in recognition
of working capital and investment requirements
► Regis has significant capacity for future greenfield and brownfield developments, as well
as material strategic acquisitions to participate in the continuing sector consolidation
Dividends
▸ FY23 interim dividend of 2.00 cents per ordinary share (50% franked) paid 14 April 2023
►FY23 final dividend of 7.48 cents per ordinary share (50% franked) payable
27 September 2023
"Cashflows from operating activities before interest, income tax and RADS
-11-
30 June 2022
Capital Expenditure
Cashflows from Operating Activities*
Net Debt ($m)
403.8
53.5
Sale of Property, Plant and Equipment
303.2
236.7
(60.0)
Dividends Paid
10.5
(43.6)
13.0
Net Finance Costs
Net RAD and Accomm Bond Inflows
Tax Paid and other Net Costs
142.4
102.9
FY18
FY19
FY20
FY21
FY22
6.0
FY23
regis healthcare
1.2
6.0
30 June 2023View entire presentation